Drug-SNPing: an integrated drug-based, protein interaction-based tagSNP-based pharmacogenomics platform for SNP genotyping

Many drug or single nucleotide polymorphism (SNP)-related resources and tools have been developed, but connecting and integrating them is still a challenge. Here, we describe a user-friendly web-based software package, named Drug-SNPing, which provides a platform for the integration of drug information (DrugBank and PharmGKB), protein-protein interactions (STRING), tagSNP selection (HapMap) and genotyping information (dbSNP, REBASE and SNP500Cancer). DrugBank-based inputs include the following: (i) common name of the drug, (ii) synonym or drug brand name, (iii) gene name (HUGO) and (iv) keywords. PharmGKB-based inputs include the following: (i) gene name (HUGO), (ii) drug name and (iii) disease-related keywords. The output provides drug-related information, metabolizing enzymes and drug targets, as well as protein-protein interaction data. Importantly, tagSNPs of the selected genes are retrieved for genotyping analyses. All drug-based and protein-protein interaction-based SNP genotyping information are provided with PCR-RFLP (PCR-restriction enzyme length polymorphism) and TaqMan probes. Thus, users can enter any drug keywords/brand names to obtain immediate information that is highly relevant to genotyping for pharmacogenomics research.

[1]  Weida Tong,et al.  ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. , 2003, Environmental health perspectives.

[2]  References , 1971 .

[3]  Jill L. Wegrzyn,et al.  PineSAP—sequence alignment and SNP identification pipeline , 2009, Bioinform..

[4]  D Bentley,et al.  The HapMap project and its application to genetic studies of drug response , 2004, The Pharmacogenomics Journal.

[5]  Li-Yeh Chuang,et al.  Seq-SNPing: multiple-alignment tool for SNP discovery, SNP ID identification, and RFLP genotyping. , 2009, Omics : a journal of integrative biology.

[6]  P. Sullivan,et al.  Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput , 2003, The Pharmacogenomics Journal.

[7]  Francesco Pinciroli,et al.  MicroGen: a MIAME compliant web system for microarray experiment information and workflow management , 2005, BMC Bioinformatics.

[8]  Rajarshi Guha,et al.  Chemical Data Mining of the NCI Human Tumor Cell Line Database , 2007, J. Chem. Inf. Model..

[9]  Li-Yeh Chuang,et al.  SNP ID-info: SNP ID searching and visualization platform. , 2008, Omics : a journal of integrative biology.

[10]  Russ B. Altman,et al.  PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single‐drug pharmacogenetics , 2008, Human mutation.

[11]  K. Abdullah,et al.  The TaqMan method for SNP genotyping. , 2009, Methods in molecular biology.

[12]  J. J. Galán,et al.  Pyrosequencing for SNP genotyping. , 2009, Methods in molecular biology.

[13]  Ralf H. Bortfeldt,et al.  CandiSNPer: a web tool for the identification of candidate SNPs for causal variants , 2010, Bioinform..

[14]  Xin Chen,et al.  DCDB: Drug combination database , 2010, Bioinform..

[15]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[16]  Michael C. Rosenstein,et al.  The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. , 2006, Journal of experimental zoology. Part A, Comparative experimental biology.

[17]  Hugues Sicotte,et al.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes , 2005, Nucleic Acids Res..

[18]  David S Wishart,et al.  In Silico Drug Exploration and Discovery Using DrugBank , 2007, Current protocols in bioinformatics.

[19]  Paul C Boutros,et al.  dbZach: A MIAME-compliant toxicogenomic supportive relational database. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  Li-Yeh Chuang,et al.  Novel generating protective single nucleotide polymorphism barcode for breast cancer using particle swarm optimization. , 2009, Cancer epidemiology.

[21]  Chih-Jen Huang,et al.  Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. , 2009, Omics : a journal of integrative biology.

[22]  A. Daly,et al.  Genome-wide association studies in pharmacogenomics , 2010, Nature Reviews Genetics.

[23]  Li-Yeh Chuang,et al.  Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio‐based genetic algorithms , 2012, The Kaohsiung journal of medical sciences.

[24]  Y. Mándi,et al.  Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease , 2008, Scandinavian journal of gastroenterology.

[25]  C. Mattingly,et al.  The Comparative Toxicogenomics Database (CTD). , 2003, Environmental health perspectives.

[26]  Wesley A. Beckstead,et al.  SNP2RFLP: a computational tool to facilitate genetic mapping using benchtop analysis of SNPs , 2008, Mammalian Genome.

[27]  George Ellis,et al.  Path: a tool to facilitate pathway-based genetic association analysis , 2009, Bioinform..

[28]  Richard J. Roberts,et al.  REBASE—a database for DNA restriction and modification: enzymes, genes and genomes , 2009, Nucleic Acids Res..

[29]  Stefan Günther,et al.  SuperSite: dictionary of metabolite and drug binding sites in proteins , 2008, Nucleic Acids Res..

[30]  PharmGED: Pharmacogenetic Effect Database , 2007, Nucleic acids research.

[31]  Thomas Schlitt,et al.  Protein-protein interaction databases: keeping up with growing interactomes , 2009, Human Genomics.

[32]  Russ B. Altman,et al.  Pharmacogenomics and bioinformatics: PharmGKB. , 2010, Pharmacogenomics.

[33]  Yu-Huei Cheng,et al.  SNP-RFLPing: restriction enzyme mining for SNPs in genomes , 2006, BMC Genomics.

[34]  Pierre Baldi,et al.  ChemDB: a public database of small molecules and related chemoinformatics resources , 2005, Bioinform..

[35]  Atsushi Ishiguro,et al.  Influence of cancer‐related gene polymorphisms on clinicopathological features in colorectal cancer , 2008, Journal of gastroenterology and hepatology.

[36]  Li-Yeh Chuang,et al.  Prim-SNPing: a primer designer for cost-effective SNP genotyping. , 2009, BioTechniques.

[37]  Li Gong,et al.  PharmGKB: An Integrated Resource of Pharmacogenomic Data and Knowledge , 2008, Current protocols in bioinformatics.

[38]  A. Salter,et al.  Large-scale databases in toxicogenomics. , 2005, Pharmacogenomics.

[39]  Pär Stattin,et al.  Cumulative association of five genetic variants with prostate cancer. , 2008, The New England journal of medicine.

[40]  Mark Craven,et al.  EDGE: A Centralized Resource for the Comparison, Analysis, and Distribution of Toxicogenomic Information , 2005, Molecular Pharmacology.

[41]  Li-Yeh Chuang,et al.  SNP-RFLPing 2: an updated and integrated PCR-RFLP tool for SNP genotyping , 2010, BMC Bioinformatics.

[42]  Stephen J. Chanock,et al.  Polymorphism Interaction Analysis (PIA): a method for investigating complex gene-gene interactions , 2008, BMC Bioinformatics.

[43]  Douglas F. Easton,et al.  Seq4SNPs: new software for retrieval of multiple, accurately annotated DNA sequences, ready formatted for SNP assay design , 2008, BMC Bioinformatics.

[44]  Xin Chen,et al.  ADME-AP: a database of ADME associated proteins , 2002, Bioinform..

[45]  Li-Yeh Chuang,et al.  Restriction enzyme mining for SNPs in genomes. , 2008, Anticancer research.

[46]  Pierre Tufféry,et al.  FAF-Drugs: free ADME/tox filtering of compound collections , 2006, Nucleic Acids Res..

[47]  R. Hartmann,et al.  Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods. , 2007, Journal of medicinal chemistry.

[48]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[49]  Li-Yeh Chuang,et al.  The importance of integrating SNP and cheminformatics resources to pharmacogenomics. , 2012, Current drug metabolism.

[50]  H. McLeod,et al.  Ability of whole-genome SNP arrays to capture 'must have' pharmacogenomic variants. , 2008, Pharmacogenomics.

[51]  Zhen Yang,et al.  MapNext: a software tool for spliced and unspliced alignments and SNP detection of short sequence reads , 2009, BMC Genomics.

[52]  G. Stormo,et al.  PolyMAPr: Programs for polymorphism database mining, annotation, and functional analysis , 2005, Human Mutation.

[53]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[54]  Pierre R. Bushel,et al.  Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application , 2006, Bioinform..

[55]  Damian Szklarczyk,et al.  STITCH 2: an interaction network database for small molecules and proteins , 2009, Nucleic Acids Res..

[56]  C. P. Morris,et al.  SNP technologies for drug discovery: a current review. , 2008, Current drug discovery technologies.

[57]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[58]  Patricia Rodriguez-Tomé,et al.  MMsINC: a large-scale chemoinformatics database , 2008, Nucleic Acids Res..

[59]  Li-Yeh Chuang,et al.  SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women. , 2008, The Chinese journal of physiology.

[60]  Walter Filgueira de Azevedo,et al.  Drug-binding databases. , 2008, Current drug targets.

[61]  Petras J. Kundrotas,et al.  GWIDD: Genome-wide protein docking database , 2009, Nucleic Acids Res..

[62]  David S Wishart,et al.  DrugBank and its relevance to pharmacogenomics. , 2008, Pharmacogenomics.

[63]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[64]  Shyun-Yeu Liu,et al.  Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[65]  R. Altman,et al.  PharmGKB: understanding the effects of individual genetic variants. , 2008, Drug metabolism reviews.

[66]  Rosalind Ramsey-Goldman,et al.  Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. , 2007, The Journal of rheumatology.

[67]  H. Hug,et al.  ADRIS – The Adverse Drug Reactions Information Scheme , 2004, Pharmacogenetics.

[68]  Yu Zong Chen,et al.  Drug Adverse Reaction Target Database (DART) , 2003, Drug safety.

[69]  Pablo Moscato,et al.  The Gene Interaction Miner: a new tool for data mining contextual information for protein-protein interaction analysis , 2010, Bioinform..